COMMUNIQUÉS West-GlobeNewswire

AXIM® Biotechnologies Launches New Website and Management Presentation To Outline Strategic Business Initiatives
15/01/2019
NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the launch of a new corporate [...]
Nova Leap Health Corp. Provides Update on Future Plans and Grants Stock Options
15/01/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Auris Medical Provides Update on Intranasal Betahistine Programs
15/01/2019
Closes acquisition of Orphan Drug Designation for betahistine for the treatment of obesity associated with Prader-Willi syndrome (PWS) Clinical trial applications for proof-of-concept studies with intranasal betahistine [...]
International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business
15/01/2019
CARLSBAD, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based, clinical stage biotechnology company [...]
Yield10 Bioscience Reports Encouraging Results from 2018 Field Tests of C3003 and Announces Advancement of C3003 into Commercial Development for Canola
15/01/2019
WOBURN, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today [...]
Medovex Corporation Announces New Board Appointments
15/01/2019
Finance Industry Veterans Join Board of Directors Following Successful Closing of Regenerative Medicine Solutions Acquisition ALPHARETTA, Ga., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“ [...]
Menlo Therapeutics’ Serlopitant Granted Breakthrough Therapy Designation by FDA for the Treatment of Pruritus Associated with Prurigo Nodularis
15/01/2019
REDWOOD CITY, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
VistaGen Therapeutics Appoints Pharmaceutical Industry Veteran, Ann Cunningham, to its Board of Directors
15/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]
Large-scale paediatric SLIT-tablet trial meets primary endpoint, confirming potential in children
15/01/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): Phase III efficacy and safety trial of ragweed SLIT-tablet involved over 1,000 children aged 5 to 17 in North America and Europe Primary endpoint was met, with a major [...]
Biomerica Announces Second Quarter Financial Results
15/01/2019
IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,500,791 for the three months ended November 30, 2018, compared to $1,613,636 for the same period in the [...]
Premier Orthopaedics selects Allscripts to provide connected health IT platform
15/01/2019
Orthopaedic group signs strategic agreement to deploy Allscripts Professional EHR™, Allscripts® Practice Management, FollowMyHealth® and full Payerpath® suite of solutions CHICAGO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- [...]
Biome Opens the Door to U.S. Investors -- CFN Media
15/01/2019
SEATTLE, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Biome Grow Inc. (CSE: BIO) began trading on the OTCQB® on January 2, 2019 with the ticker symbol “BIOIF”. While the company was already listed on the OTC [...]
Forty Seven Inc. to Host Key Opinion Leader Breakfast Symposium on FSI-174, anti-cKIT Antibody, on January 22, 2019
15/01/2019
MENLO PARK, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Apotheca Biosciences (PCFP) Introduces ProMED, Our Newest Flagship Product Line -- Company Begins Rolling Out its Sleep Aid & Opioid Replacement Formulations
15/01/2019
Saint Petersburg, FL, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
PetMed Express d/b/a 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2019
15/01/2019
DELRAY BEACH, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended December 31, 2018 on Tuesday, January 22, 2019 at 8:00 A.M. Eastern [...]
Galectin Therapeutics’ Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Streamlining Its Capital Structure
15/01/2019
Board Chairman Richard Uihlein extends existing $10 million unsecured line of credit for two additional years NORCROSS, Ga., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading [...]
AMAG Pharmaceuticals Appoints Christine Moulton Clemson, Ph.D., M.S.C.I. as Vice President of Medical Affairs
15/01/2019
WALTHAM, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Christine Moulton Clemson, Ph.D., M.S.C.I., as vice president, medical affairs, reporting to [...]
Extendicare Announces January 2019 Dividend of C$0.04 per Share
15/01/2019
MARKHAM, Ontario, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
TRHC Commends Centers for Medicare and Medicaid Services on Creation of New Opportunities for Dual Medicaid and Medicare Patients
15/01/2019
New recommendations highlight positive changes for PACE participants MOORESTOWN, N.J., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the [...]

Pages